Kinetics and neuropsychologic effects of IV diazepam in the presence and absence of its active N-desmethyl metabolite in humans
- PMID: 6777807
- DOI: 10.1007/BF00427892
Kinetics and neuropsychologic effects of IV diazepam in the presence and absence of its active N-desmethyl metabolite in humans
Abstract
In 12 healthy volunteers the kinetics and neuropsychological actions of IV diazepam (DZ) (single dose) were studied with and without the presence of its main metabolite N-desmethyldiazepam (NDDZ). Both the maximal plasma concentration and the steepness of the alpha-slope were correlated with variations in the corresponding continuous reaction time (CRT). EEG profiles, CRT and clinical ratings for anxiety and sedation all showed significant changes between the situations with the metabolite present or absent, but no significant correlation could be found with the kinetic pattern of DZ in the two situations. Tolerance to NDDZ did not develop. The results indicate that the presence of the active metabolite changes the pharmacodynamic profile of the parent compound probably by an interaction at the receptor site between DZ and NDDZ. Changes in the spectrum of effects during long-term therapy with DZ may, therefore, partly be explained in this way.
Similar articles
-
Anxiety and sedation during a stressful situation after single dose of diazepam versus N-desmethyldiazepam--a controlled trial.Psychopharmacology (Berl). 1980;70(3):303-5. doi: 10.1007/BF00427891. Psychopharmacology (Berl). 1980. PMID: 6777806 Clinical Trial.
-
Determination of pharmacodynamics of diazepam by quantitative pharmaco-EEG.Jpn J Psychiatry Neurol. 1989 Dec;43(4):675-84. doi: 10.1111/j.1440-1819.1989.tb03102.x. Jpn J Psychiatry Neurol. 1989. PMID: 2517763
-
Effects of desmethyldiazepam on diazepam kinetics: a study of effects of a metabolite on parent drug disposition.Clin Pharmacol Ther. 1981 Jun;29(6):757-61. doi: 10.1038/clpt.1981.107. Clin Pharmacol Ther. 1981. PMID: 6784999
-
Clearance of diazepam can be impaired by its major metabolite desmethyldiazepam.Eur J Clin Pharmacol. 1981;21(2):161-3. doi: 10.1007/BF00637518. Eur J Clin Pharmacol. 1981. PMID: 6804244 Clinical Trial.
-
[Clinical pharmacokinetics of diazepam and its biologically active metabolites (author's transl)].Klin Wochenschr. 1978 Sep 15;56(18):895-904. doi: 10.1007/BF01489215. Klin Wochenschr. 1978. PMID: 362051 Review. German.
Cited by
-
N-desmethylclobazam: a possible alternative to clobazam in the treatment of refractory epilepsy?Br J Clin Pharmacol. 1987 Feb;23(2):213-8. doi: 10.1111/j.1365-2125.1987.tb03032.x. Br J Clin Pharmacol. 1987. PMID: 3828198 Free PMC article.
-
Anxiety and sedation during a stressful situation after single dose of diazepam versus N-desmethyldiazepam--a controlled trial.Psychopharmacology (Berl). 1980;70(3):303-5. doi: 10.1007/BF00427891. Psychopharmacology (Berl). 1980. PMID: 6777806 Clinical Trial.
-
Development of tolerance and cross-tolerance to the psychomotor actions of lorazepam and diazepam in man.Br J Clin Pharmacol. 1983 May;15(5):545-52. doi: 10.1111/j.1365-2125.1983.tb02088.x. Br J Clin Pharmacol. 1983. PMID: 6134543 Free PMC article. Clinical Trial.
-
A double-blind study of the sedative effects of the thalidomide enantiomers in humans.J Pharmacokinet Biopharm. 1998 Aug;26(4):363-83. doi: 10.1023/a:1021008016719. J Pharmacokinet Biopharm. 1998. PMID: 10214558 Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials